PTC Therapeutics
PTCT
PTCT
180 hedge funds and large institutions have $2.2B invested in PTC Therapeutics in 2018 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 49 increasing their positions, 60 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.86% more ownership
Funds ownership: 92.33% → 93.19% (+0.86%)
18% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 60
30% less call options, than puts
Call options by funds: $22.3M | Put options by funds: $31.9M
Holders
180
Holding in Top 10
7
Calls
$22.3M
Puts
$31.9M
Top Buyers
| 1 | +$123M | |
| 2 | +$85.7M | |
| 3 | +$68.7M | |
| 4 |
O
OrbiMed
New York
|
+$59.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$59.3M |
Top Sellers
| 1 | -$75.7M | |
| 2 | -$59.6M | |
| 3 | -$40M | |
| 4 |
RI
RTW Investments
New York
|
-$37.5M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$32.3M |